Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs

Hypertension

Volumn 63, Issue 5, 2014, Pages 958-967

  Wang, Tzung Dau ^a   Chen, Ying Hsien ^a   Huang, Chien Hua ^a   Chen, Wen Jone ^a   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antihypertensive agents; Drug combinations; Hypertension; Medication adherence; Polypharmacy; Population

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DRUG FORMULATION; DRUG SUBSTITUTION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL HEALTH INSURANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SINGLE PILL COMBINATION;

ANTIHYPERTENSIVE AGENTS; DRUG COMBINATIONS; HYPERTENSION; MEDICATION ADHERENCE; POLYPHARMACY; POPULATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DATABASES, FACTUAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SEX FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TAIWAN;

EID: 84902275601     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02455     Document Type: Article

References (33)

1. Sever PS, Messerli FH Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011; 32: 2499-2506.
2. Mancia G, Fagard R, Narkiewicz K., et al.; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31: 1281-1357.
3. Chiang CE, Wang TD, Li Y.H., Lin TH, Chien KL, Yeh HI, Shyu K.G., Tsai WC, Chao TH, Hwang JJ, Chiang FT, Chen JH; Hypertension Committee of the Taiwan Society of Cardiology. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc. 2010; 109: 740-773.
4. Gu Q, Burt VL, Dillon C.F., Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012; 126: 2105-2114.
5. Ockene JK, Schneider KL, Lemon S.C., Ockene IS Can we improve adherence to preventive therapies for cardiovascular health? Circulation. 2011; 124: 1276-1282.
6. Chobanian AV, Bakris GL, Black H.R., Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-2572. (Pubitemid 37430158)
7. McManus RJ, Caulfield M, Williams B., National Institute for H, Clinical E. Nice hypertension guideline 2011: evidence based evolution. BMJ. 2012; 344:e181.
8. Gupta AK, Arshad S, Poulter NR Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010; 55: 399-407.
9. Asplund J, Danielson M, Ohman P. Patients compliance in hypertension-the importance of number of tablets. Br J Clin Pharmacol. 1984; 17: 547-552. (Pubitemid 14057461)
10. Solomon LR, Dawes PM Treatment of essential hypertension with a combination of propranolol and bendrofluazide. J Int Med Res. 1980; 8: 34-37. (Pubitemid 10211145)
11. Nielsen J, Kane JM, Correll CU Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study. Bipolar Disord. 2012; 14: 863-869.
12. Hsu CN, Wang TD Secular trends in prescription patterns of single-pill combinations of an angiotensin-converting enzyme inhibitor or angioten-sin receptor blocker plus a thiazide diuretic for hypertensive patients in Taiwan. Acta Cardiol Sinica. 2013; 29: 49-55.
13. Mazzaglia G, Ambrosioni E, Alacqua M., Filippi A, Sessa E, Immordino V., Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009; 120: 1598-1605.
14. Ho PM, Bryson CL, Rumsfeld JS Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119: 3028-3035.
15. Bramley TJ, Gerbino PP, Nightengale B.S., Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006; 12: 239-245. (Pubitemid 47400613)
16. Charlson ME, Pompei P, Ales K.L., MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383. (Pubitemid 17055592)
17. Naderi SH, Bestwick JP, Wald DS Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012; 125: 882-887.e1.
18. Vrijens B, Vincze G, Kristanto P., Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008; 336: 1114-1117. (Pubitemid 351731741)
19. Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013; 62: 218-225.
20. Choudhry NK, Avorn J, Glynn R.J., Antman EM, Schneeweiss S, Toscano M, Reisman L., Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH; Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011; 365: 2088-2097.
21. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med. 2010; 362: 1553-1555.
22. Long JA, Jahnle EC, Richardson D.M., Loewenstein G., Volpp KG Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med. 2012; 156: 416-424.
23. Viswanathan M, Golin CE, Jones C.D., Ashok M., Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012; 157: 785-795.
24. Chapman RH, Benner JS, Petrilla A.A., Tierce JC, Collins SR, Battleman DS, Schwartz JS Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165: 1147-1152. (Pubitemid 40720739)
25. Sherrill B, Halpern M, Khan S., Zhang J, Panjabi S. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich). 2011; 13: 898-909.
26. Hess G, Hill J, Lau H., Dastani H, Chaudhari P. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. P T. 2008; 33: 652-666.
27. Matsumura K, Arima H, Tominaga M., Ohtsubo T, Sasaguri T, Fujii K., Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T; COMFORT Investigators. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial. Circ J. 2012; 76: 1415-1422.
28. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353: 487-497. (Pubitemid 41127293)
29. Grigoryan L, Pavlik VN, Hyman DJ Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012; 25: 735-738.
30. Shalansky SJ, Levy AR Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002; 36: 1532-1539.
31. Egan BM, Bandyopadhyay D, Shaftman S.R., Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012; 59: 1124-1131.
32. Feldman RD, Zou GY, Vandervoort M.K., Wong CJ, Nelson SA, Feagan BG A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension. 2009; 53: 646-653.
33. Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J. 2013; 34: 1262-1269.